Navigation Links
Rutgers researchers discover how HIV resists AZT
Date:9/19/2010

NEW BRUNSWICK, N.J. Rutgers researchers have discovered how HIV-1, the virus that causes AIDS, resists AZT, a drug widely used to treat AIDS.

The scientists, who report their findings in Nature Structural & Molecular Biology, believe their discovery helps researchers understand how important anti-AIDS treatments can fail and could help AIDS researchers develop more effective treatment for the disease.

"What we've found is the detailed way in which the mutations act to promote the resistance," said author Eddy Arnold, Board of Governors Professor of Chemistry and Chemical Biology, and a resident faculty member of the Center for Advanced Biotechnology and Medicine. "Instead of blocking the actions of AZT, the virus actually removes it, and it does so by using ATP, one of the most common cellular molecules. This is an outstanding example of how sneaky HIV can be in thwarting the efficacy of therapeutic drugs."

AZT was once the only treatment for AIDS, and it remains an important treatment, particularly in preventing the transmission of the virus from infected mothers to their unborn children.

Researchers knew almost from the beginning that the virus developed resistance to AZT, and that this resistance had to do with mutations, but the way the mutations worked to resist the drug was mysterious.

AZT works by inhibiting an enzyme, reverse transcriptase, which HIV needs to produce DNA from RNA, and thus replicate itself. About 10 years ago, biochemical studies in several laboratories established that AZT-resistant HIV-1 reverse transcriptase uses adenosine triphosphate, or ATP, which moves energy around inside the cell, to remove the AZT. Arnold and his co-authors have used X-ray crystallography to describe in atomic detail how the AZT-resistance mutations allow reverse transcriptase to recruit ATP to remove the AZT.


'/>"/>

Contact: Ken Branson
kbranson@ur.rutgers.edu
908-797-2590
Rutgers University
Source:Eurekalert

Page: 1

Related medicine news :

1. Reality TV, cosmetic surgey linked, says Rutgers-Camden researcher
2. Rutgers and the Prostate Net host prostate cancer symposium, May 15
3. Dr. Carl Djerassi, inventor of The Pill, to receive honorary doctorate from Rutgers University
4. Rutgers Stem Cell Research Center derives new cell lines and trains stem cell scientists
5. Rutgers historian puts 50th anniversary of the pill into cultural medicine cabinet
6. Rutgers University Offers Fundamentals of Finance and Accounting Workshop at Mount Laurel, New Jersey Location Aimed at Non-Financial Managers
7. Snowmen Notwithstanding, It's Time To Register For Rutgers' Summer Session
8. Researchers at SUNY Downstate find drug combination may treat traumatic brain injury
9. Do the math, say UCLA researchers
10. MIT researchers discover an unexpected twist in cancer metabolism
11. OHSU researchers able to determine brain maturity through analyzing MRI scans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... FRIDAY, Dec. 19, 2014 (HealthDay News) -- U.S. and ... to caramel apples that has killed at least four ... Consumers should not eat any commercially produced, prepackaged caramel ... for Disease Control and Prevention said in a news ... 28 people had been infected with the outbreak strains ...
(Date:12/22/2014)... 2014 Physicians in China are most ... treatment of non-Hodgkin’s lymphoma (NHL), according to a new ... healthcare consulting firm. MabThera is the only biologic available ... common form of NHL. , According to Kantar Health’s ... incidence of NHL in China has been growing and ...
(Date:12/22/2014)... Colorado (PRWEB) December 22, 2014 Super ... Black Friday this year as the busiest day in ... other retailers, The Grass Station had a steady pre-Christmas ... holiday gifts, this past Saturday. , “I definitely intend ... 33-year-old Robert, a Denver resident who was enjoying The ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 Only weeks ... southern and mid-western cities to have a battery manufacturer ... TalkLocal ( http://www.talklocal.com ) is launching in Henderson ... economy. , “A strong manufacturing sector is going ... founder Gurpreet Singh explained, “and TalkLocal works with small ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount Labels ... a local organization that provides services to veterans and ... on a couple hundred acres in the hills of ... class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet shooting, ... ago to support U.S. Service men and women, police ...
Breaking Medicine News(10 mins):Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 2Health News:Physicians in China See Most Significant Demand for MabThera Biosimilar 3Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:TalkLocal Launches in Henderson Weeks Following New Megafactory, New Jobs Announcement 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2
... Capital BlueCross announced today that it will cover an ... and those with individual coverage during the upcoming 2009-2010 flu ... to include this benefit. , , A ... October. Various clinical vaccine trials have begun, some under the ...
... NEW YORK, Sept. 16 Dr. Mark Hasten, chairman of the ... Kadish, M.D., as senior provost and chief operating officer for Touro ... http://www.flickr.com/photos/tourocollege/3923514965/ , , Touro is ... college was founded by Dr. Bernard Lander in 1970, originally as ...
... , FARMINGTON HILLS, Mich., Sept. ... stock and assets of GTL, Inc. dba as "Link to ... product and service offerings into CST to provide cost-effective personal ... and quality of life for older adults, the disabled and ...
... 20% of emergency room visits and 5% of ... first-line treatment option in patients with gastrointestinal bleeding, ... diagnostic and treatment method in patients with gastrointestinal ... incidence of rebleeding in patients with negative initial ...
... HEATHROW, Fla., Sept. 16 Cozmix, Inc., a sales ... beta release of SizeMix, the sales industry,s first point and ... forms a core component of Cozmix, SizeMix Process. , ... components necessary to complete a full internal review of a ...
... , BALTIMORE, Sept. 16 While most men ... likely unaware of other important statistics that could one day save ... and the National Football League (NFL) are teaming to encourage men ... of cancer death for American men. Men and their loved ones ...
Cached Medicine News:Health News:Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 2Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 3Health News:Touro Appoints Alan Kadish, M.D., Senior Provost and Chief Operating Officer 4Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 2Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 3Health News:Sales Force Sizing and Resource Optimization Software Is the First of Its Kind to Enter the Market (Beta Release) 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 2Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 3Health News:Video: NFL Season Kicks Off With Campaign to 'Know Your Stats About Prostate Cancer' 4
(Date:12/22/2014)... , Dec. 22, 2014 Research and ... the addition of the "Investment Analysis of ... to their offering. ... in the US medical device sector identifies the ... and venture capital investments, and mergers and acquisitions. ...
(Date:12/22/2014)... CHESTERBROOK, Pa. and STOCKHOLM ... AB (publ) (Sobi) and partner Auxilium Pharmaceuticals, Inc. today ... Use (CHMP) of the European Medicines Agency (EMA) has ... (collagenase clostridium histolyticum) for the treatment of adult men ... deformity of at least 30 degrees at the start ...
(Date:12/22/2014)... PALO ALTO, Calif. , Dec, 22, 2014 ... of a Phase 2a study of lonafarnib in ...  The study was conducted at the National Institutes ... Bethesda, Maryland .  The double-blinded, randomized, placebo-controlled, ... 100 mg twice daily and 200 mg twice ...
Breaking Medicine Technology:Investment Analysis of the US Medical Device Sector 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 2Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 3Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 4Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 5Sobi's Xiapex receives positive opinion by CHMP for the treatment of Peyronie's disease 6Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 2Eiger Bio Announces Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib - Results Presented at American Association for the Study of Liver Diseases (AASLD) Meeting 3
... Aug. 23 Biopure Corporation,(Nasdaq: BPUR ) ... clinical,study protocol to the FDA for compassionate use ... States. The proposed open label,study would make Hemopure ... or potentially life threatening anemia on a compassionate ...
... Alfacell Corporation,(Nasdaq: ACEL ) today announced that ... (2007; Vol. 31, Issue 3: 663-669) reports that,ONCONASE(R) ... types and tumor cell lines. The observed antioxidant ... effect on cancer cells and,mechanistic synergism with other ...
Cached Medicine Technology:Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 2Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia 3Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 2Paper in International Journal of Oncology Reports Alfacell's ONCONASE(R) Suppresses Intracellular Oxidative Stress 3
Ballard trach care HMES and filters, tv 1500, HME with built-in flex tube...
... Portex® Thermovent® T helps provide protection to the ... small and extremely lightweight making it ideal for ... a high rate of heat and moisture recovery, ... ,All HMEs and filters have ISO standard ...
... protection to the exposed airway of the tracheostomy ... it ideal for active young children as well ... and moisture recovery, it ensures patient comfort and ... have ISO standard tapered ends to assure a ...
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
Medicine Products: